Search results
Results From The WOW.Com Content Network
The Vanderbilt ADHD Diagnostic Rating Scale (VADRS) is a psychological assessment tool for attention deficit hyperactivity disorder (ADHD) symptoms and their effects on behavior and academic performance in children ages 6–12.
The Disruptive Behavior Disorders Rating Scale (DBDRS) is a 45-question screening measure, completed by either parents or teachers, designed to identify symptoms of attention deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder in children and adolescents.
The Swanson, Nolan and Pelham Teacher and Parent Rating Scale (SNAP), developed by James Swanson, Edith Nolan and William Pelham, is a 90-question self-report inventory designed to measure attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) symptoms in children and young adults.
Like on the preschool version, the school-age version of the CBCL (CBCL/6-18) instructs a respondent who knows the child well (usually a parent or other close caregiver) to report on the child's problems. Alternative measures are available for teachers (the Teacher's Report Form) and the child (the Youth Self Report, for youths age 11 to 18 years).
The questionnaire takes 3–10 minutes to complete. There are now self-report (completed by the youth), parent-report, and teacher-report versions. A version designed for adults (age 18+ years) to fill out about themselves has also been developed.
McNeil Nutritionals, LLC markets and sells a range of products including Lactaid, and Benecol in the UK, Ireland, Belgium, and in the US under license from Raisio Group. In June 2007, McNeil became involved in lawsuits with Merisant , the makers of the artificial sweetener Equal . [ 8 ]
The Crowell procedure is a tool used to assess the parent-child relationship. [1] Crowell and Feldman created the assessment tool for use in a study. [2] The tool, which includes seven activities for the parent-child dyad to complete, is used for both preventive and clinical purposes. [1]
Ortho-McNeil's parent company, Johnson and Johnson, also paid $75.37 million to resolve civil allegations under the False Claims Act that it caused false claims to be submitted to government health care programs for a variety of psychiatric uses that were not FDA approved.